Drug-DNA interactions and novel drug design

被引：45

作者：

Gibson D. ^{[1
]}

机构：

[1] Dept. of Med. Chem./Natural Products, School of Pharmacy, The Hebrew University of Jerusalem, Jerusalem

来源：

关键词：

D O I：

10.1038/sj.tpj.6500133

中图分类号：

学科分类号：

摘要：

[No abstract available]

引用

页码：275 / 276

页数：1

共 14 条

[1]

Casey B.P., Et al., Prog. Neucleic Acid Res. Mol. Biol., 67, pp. 163-192, (2001)

[2]

Gambari R., Curr. Pharm. Des., 7, pp. 1839-1862, (2001)

[3]

Raymond E., Et al., Invest. New Drug, 18, pp. 123-137, (2000)

[4]

Brenner S., Et al., J. Mol. Biol., 3, (1961)

[5]

Peacocke A.R., Et al., Trans. Faraday Soc., 52, (1956)

[6]

Scatchard G., Ann. N. Y. Acad. Sci., 51, (1949)

[7]

Chairns J.B., Waring M.J., Methods in Enzymology, (2001)

[8]

Gao X.L., Et al., Q. Rev. Biophys., 22, pp. 93-138, (1989)

[9]

Haq I., Et al., J. Mol. Recog., 13, pp. 188-197, (2000)

[10]

Berman H.M., Et al., Prog. Biophys Mol. Biol., 66, (1996)